tiprankstipranks
Niagen Bioscience (DE:OCD1)
FRANKFURT:OCD1
Germany Market
OCD1
Niagen Bioscience
RESEARCH TOOLSreports

Niagen Bioscience (OCD1) Ratios

2 Followers

Niagen Bioscience Ratios

DE:OCD1's free cash flow for Q2 2026 was $0.65. For the 2026 fiscal year, DE:OCD1's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.50 4.86 3.57 2.40 2.61
Quick Ratio
 5.13 3.83 3.06 1.70 1.78
Cash Ratio
 4.43 3.25 2.48 1.32 1.14
Solvency Ratio
 0.74 0.63 0.45 -0.12 -0.58
Operating Cash Flow Ratio
 0.40 0.67 0.67 0.35 -0.84
Short-Term Operating Cash Flow Coverage
 0.00 13.41 0.00 0.00 0.00
Net Current Asset Value
$ 73.72M$ 66.93M$ 41.92M$ 23.03M$ 21.18M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.03 0.04 0.06 0.08
Debt-to-Equity Ratio
 0.03 0.04 0.06 0.12 0.15
Debt-to-Capital Ratio
 0.03 0.04 0.05 0.10 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.39 1.48 1.93 1.89
Debt Service Coverage Ratio
 0.00 18.79 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.03 0.04 0.03 0.05 0.06
Net Debt to EBITDA
 -3.49 -3.16 -4.05 6.14 0.96
Profitability Margins
Gross Profit Margin
64.24%64.28%61.84%60.76%59.40%
EBIT Margin
12.91%14.06%8.89%-6.70%-25.85%
EBITDA Margin
14.32%15.18%10.38%-4.66%-23.24%
Operating Profit Margin
6.67%11.05%7.76%-6.70%-25.85%
Pretax Profit Margin
13.19%14.06%8.89%-5.91%-22.96%
Net Profit Margin
12.39%13.43%8.58%-5.91%-22.96%
Continuous Operations Profit Margin
12.39%13.43%8.58%-5.91%-22.96%
Net Income Per EBT
93.91%95.55%96.56%100.00%100.00%
EBT Per EBIT
197.66%127.25%114.61%88.19%88.79%
Return on Assets (ROA)
15.00%16.34%12.52%-8.98%-30.60%
Return on Equity (ROE)
20.50%22.71%18.55%-17.35%-57.69%
Return on Capital Employed (ROCE)
9.41%16.53%15.35%-16.30%-51.48%
Return on Invested Capital (ROIC)
8.75%15.61%14.53%-15.98%-50.50%
Return on Tangible Assets
15.79%17.25%12.59%-9.07%-30.98%
Earnings Yield
6.63%3.45%1.88%-4.90%-14.29%
Efficiency Ratios
Receivables Turnover
 15.04 13.29 12.82 15.97 8.49
Payables Turnover
 4.89 4.28 4.46 3.20 3.02
Inventory Turnover
 2.24 2.26 4.14 2.26 1.99
Fixed Asset Turnover
 41.82 36.82 28.88 18.42 11.40
Asset Turnover
 1.21 1.22 1.46 1.52 1.33
Working Capital Turnover Ratio
 1.56 2.10 2.65 2.90 2.40
Cash Conversion Cycle
 112.83 103.48 34.86 70.65 105.33
Days of Sales Outstanding
 24.26 27.47 28.47 22.86 42.97
Days of Inventory Outstanding
 163.20 161.24 88.27 161.68 183.13
Days of Payables Outstanding
 74.63 85.23 81.87 113.90 120.77
Operating Cycle
 187.46 188.71 116.73 184.54 226.10
Cash Flow Ratios
Operating Cash Flow Per Share
 0.07 0.17 0.14 0.10 -0.22
Free Cash Flow Per Share
 0.07 0.17 0.14 0.10 -0.22
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.95 0.98 0.99 0.98 1.02
Dividend Paid and CapEx Coverage Ratio
 21.63 46.02 74.29 48.09 -45.20
Capital Expenditure Coverage Ratio
 21.63 46.02 74.29 48.09 -45.20
Operating Cash Flow Coverage Ratio
 2.55 4.77 4.57 2.17 -3.55
Operating Cash Flow to Sales Ratio
 0.05 0.10 0.12 0.09 -0.21
Free Cash Flow Yield
2.34%2.61%2.63%6.91%-13.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.65 28.91 53.10 -20.43 -7.00
Price-to-Sales (P/S) Ratio
 1.88 3.89 4.55 1.21 1.61
Price-to-Book (P/B) Ratio
 2.92 6.58 9.84 3.54 4.04
Price-to-Free Cash Flow (P/FCF) Ratio
 42.67 38.31 37.97 14.48 -7.50
Price-to-Operating Cash Flow Ratio
 40.53 37.48 37.46 14.17 -7.67
Price-to-Earnings Growth (PEG) Ratio
 -0.90 0.29 -0.22 0.29 0.17
Price-to-Fair Value
 2.92 6.58 9.84 3.54 4.04
Enterprise Value Multiple
 9.62 22.48 39.82 -19.77 -5.96
Enterprise Value
 177.71M 441.60M 411.74M 76.98M 99.75M
EV to EBITDA
 9.62 22.48 39.82 -19.77 -5.96
EV to Sales
 1.38 3.41 4.13 0.92 1.38
EV to Free Cash Flow
 31.32 33.59 34.47 11.05 -6.46
EV to Operating Cash Flow
 29.87 32.86 34.00 10.82 -6.61
Tangible Book Value Per Share
 0.97 0.90 0.54 0.40 0.41
Shareholders’ Equity Per Share
 1.04 0.97 0.54 0.40 0.42
Tax and Other Ratios
Effective Tax Rate
 0.06 0.04 0.03 0.00 0.00
Revenue Per Share
 1.63 1.63 1.17 1.18 1.05
Net Income Per Share
 0.20 0.22 0.10 -0.07 -0.24
Tax Burden
 0.94 0.96 0.97 1.00 1.00
Interest Burden
 1.02 1.00 1.00 0.88 0.89
Research & Development to Revenue
 0.05 0.05 0.06 0.06 0.07
SG&A to Revenue
 0.53 0.48 0.48 0.30 0.39
Stock-Based Compensation to Revenue
 0.05 0.05 0.04 0.06 0.08
Income Quality
 0.37 0.77 1.42 -1.44 0.91
Currency in USD